Stay updated on Melflufen Combo in Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Melflufen Combo in Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Melflufen Combo in Myeloma: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a clinical trial evaluating melflufen in combination with dexamethasone for patients with relapsed or refractory multiple myeloma.
    Difference
    0.1%
    Check dated 2024-06-06T16:02:15.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as general health condition or prior treatments. This change clarifies the criteria used to select participants for the study.
    Difference
    27%
    Check dated 2024-05-22T12:52:48.000Z thumbnail image
  8. Check
    41 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention possibly related to medical and healthcare publications and documentation.
    Difference
    1%
    Check dated 2024-05-01T17:32:37.000Z thumbnail image

Stay in the know with updates to Melflufen Combo in Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Melflufen Combo in Myeloma: Clinical Trial page.